SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 22.20
-1.05 (-4.52%)
Mar 26, 2025, 11:41 AM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 53.11 million as of March 26, 2025. Its market cap has increased by 259.08% in one year.
Market Cap
53.11M
Enterprise Value
53.13M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.20
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 53.11M, an increase of 237.67%. That is a compound annual growth rate of 16.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.58B |
| GSK plc | 60.54B |
| Haleon | 34.83B |
| Smith & Nephew | 9.43B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.38B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.28B |